Natrijev Klorid In Glukoza Braun (Sodium Chloride, Glucose Monohydrate)

Sodium chloride, the active ingredient in Natrijev Klorid In Glukoza Braun, is an electrolyte and carbohydrate solution presented as an injectable solution for intravenous use. It helps restore extracellular fluid volume and provides glucose for cellular energy in patients requiring fluid and electrolyte replacement.

GNH USA supplies Natrijev Klorid In Glukoza Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for clinical settings, including emergency departments and intensive care units.

Natrijev Klorid In Glukoza Braun is used for fluid and electrolyte management and glucose supplementation in clinical settings.

- Fluid and electrolyte replacement: restores intravascular volume and corrects sodium and chloride deficits. - Hypoglycemia treatment: delivers rapid glucose to raise blood‑sugar levels. - Parenteral nutrition: supplies both electrolytes and carbohydrate as part of total parenteral nutrition regimens.

Adverse reactions may occur with any intravenous solution. Monitoring during infusion is essential.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Hyperglycemia: increased blood glucose concentrations. - Phlebitis: inflammation of the vein at the infusion site.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring emergency treatment. - Severe hypernatremia with neurological signs: confusion, seizures, or coma. - Pulmonary edema: fluid overload leading to respiratory distress.

Use of Natrijev Klorid In Glukoza Braun requires careful clinical assessment. - Assess baseline electrolyte status: obtain serum sodium and chloride levels before infusion. - Monitor blood glucose: check glucose concentrations during and after administration. - Adjust infusion rate in cardiac or renal impairment: avoid rapid volume expansion. - Avoid rapid infusion in neonates and infants: use weight‑based dosing protocols. - Use aseptic technique: ensure sterile handling of the injection solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intravenous fluids can interact with other medications and solutions.

Major Interactions (Avoid): - Hypertonic saline co‑administration: may cause excessive sodium load. - High‑dose insulin therapy: concurrent glucose infusion can mask hypoglycemia. - Loop diuretics: increase risk of electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Other IV electrolyte solutions: monitor cumulative sodium and chloride intake. - Blood products: watch for additive electrolyte effects. - Medications affecting glucose metabolism (e.g., oral hypoglycemics): adjust glucose monitoring frequency.